InsidersTradesSigma
Explore the detailed record of transactions filed by MANUSO JAMES S J, Director. Officer active across 1 companies, notably Ocuphire Pharma, Inc.. In total, 3 filings have been recorded. Total volume traded: €22k. The latest transaction was disclosed on 20 May 2022 — Acquisition. Regulator: SEC (Form 4). All data is openly available.
3 of 3 declarations
James S J Manuso is a Director at Ocuphire Pharma, Inc. He contributes to the governance of the company by bringing his expertise in strategy and business development. James is involved in key decisions that influence the future of Ocuphire Pharma.